Why Aurora Cannabis (TSX:ACB) Needs to Find a Partner Now More Than Ever

One way for Aurora Cannabis Inc (TSX:ACB)(NYSE:ACB) to build trust with investors is to get a big company on board as an investor, to help show that it is a safe investment.

| More on:
Female scientist in a hemp field checking plants and flowers, alternative herbal medicine concept

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

The cannabis industry is seeing a lot of red lately as investors have been rushing to hit the “sell” button on concerns related to poor governance. In what’s become a bit of a Wild West, there’s been no shortage of regulatory issues and concerns recently.

For Aurora Cannabis Inc (TSX:ACB)(NYSE:ACB), it could use a strategic partner from another industry to help give investors some much-needed confidence in the stock.

The company has already brought on some well-connected individuals into the fold that should give the Aurora access to some big public companies.

However, we still haven’t seen anything materialize on that front, and certainly nothing that resembles the Constellation Brands deal with rival pot company Canopy Growth Corp.

While critics may say that having a partner like Constellation led to Canopy’s Co-CEO Bruce Linton parting ways with the company, it’s also an indication that the beer maker wanted to ensure that operations were stronger and more likely to be profitable in the future.

It may not be popular for the growth investors who may only be looking for growth at all costs; overall, a focus on operations and processes is the way to ensure some long-term stability for the company.

For Aurora, having an established organization involved will help provide investors with some trust, as there would be too much to lose for a reputable company to be involved with illegal cannabis operations.

It would give Aurora a strong reputation to fall back on — and that could go a long way with investors who might be more than a little shaken given recent developments in the industry.

However, finding a deal has proven to be a challenge for the company, as Aurora has been noticeably quiet in terms of mergers and acquisitions lately, which wasn’t always the case for the company.

While there’s undoubtedly been interest from other industries in the past, there have also been many companies that have not just been on the fence, but they’ve also expressed a disinterest in being associated with cannabis entirely.

With Constellation seeing its results weighed down by its investment in cannabis and the industry looking even riskier than it was in the past, finding a deal with a good company may be harder than ever for Aurora — assuming that it’s looking for one, that is.

Bottom line

Trust is at a premium in the industry these days, and one way for Aurora to generate a lot of it in a short period is to have a big name company invested in it, as that would certainly give Aurora’s operations a vote of confidence, which would likely translate to more trust with investors as well.

The downside in finding a deal, which we’ve seen with Canopy Growth’s situation, is that it might mean giving up a little control of the company and having to do things a different way.

However, over the long run, having a big company helping navigate to through these challenging times could make the stock a much more attractive buy for investors.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor David Jagielski has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »